rs144055758
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 0 | common in clinvar |
(A;G) | 3 | cystic fibrosis carrier (most likely) |
Make rs144055758(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 7 |
Position | 117610625 |
Gene | CFTR |
is a | snp |
is | mentioned by |
dbSNP | rs144055758 |
dbSNP (classic) | rs144055758 |
ClinGen | rs144055758 |
ebi | rs144055758 |
HLI | rs144055758 |
Exac | rs144055758 |
Gnomad | rs144055758 |
Varsome | rs144055758 |
LitVar | rs144055758 |
Map | rs144055758 |
PheGenI | rs144055758 |
Biobank | rs144055758 |
1000 genomes | rs144055758 |
hgdp | rs144055758 |
ensembl | rs144055758 |
geneview | rs144055758 |
scholar | rs144055758 |
rs144055758 | |
pharmgkb | rs144055758 |
gwascentral | rs144055758 |
openSNP | rs144055758 |
23andMe | rs144055758 |
SNPshot | rs144055758 |
SNPdbe | rs144055758 |
MSV3d | rs144055758 |
GWAS Ctlg | rs144055758 |
Max Magnitude | 3 |
aka c.3095A>G, p.Tyr1032Cys or Y1032C
In the CFTR2 database, the minor allele is considered to be of varying clinical consequence. In a functional study, it shows 20.6% of wild-type CFTR activity.[PMID 29805046]
ClinVar | |
---|---|
Risk | rs144055758(G;G) |
Alt | rs144055758(G;G) |
Reference | Rs144055758(A;A) |
Significance | Pathogenic |
Disease | Cystic fibrosis |
Variation | info |
Gene | CFTR |
CLNDBN | Cystic fibrosis |
Reversed | 0 |
HGVS | NC_000007.13:g.117250679A>G |
CLNSRC | ClinVar LabCorp |
CLNACC | RCV000029516.2, |
[PMID 9272157] Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens.
[PMID 12133923] Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
[PMID 16801189] Identification of the 5T-12TG allele of the cystic fibrosis transmembrane conductance regulator gene in hypertrypsinaemic newborns.
[PMID 20059485] Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?